Estimating the Economic and Clinical Value of Introducing Ceftazidime/Avibactam into Antimicrobial Practice in Japan: A Dynamic Modelling Study

BACKGROUND: Antimicrobial resistance (AMR) is one of the most serious public health challenges worldwide, including in Japan. Globally, research and development of new antimicrobials has stalled due to unfavorable market conditions, which undervalue antimicrobials. Furthermore, Japan faces the addit...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumoto, Tetsuya, Yuasa, Akira, Miller, Ryan, Pritchard, Clive, Ohashi, Takahisa, Taie, Amer, Gordon, Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476387/
https://www.ncbi.nlm.nih.gov/pubmed/36107306
http://dx.doi.org/10.1007/s41669-022-00368-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476387/
https://www.ncbi.nlm.nih.gov/pubmed/36107306
http://dx.doi.org/10.1007/s41669-022-00368-w

Ejemplares similares